Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
doi: 10.1093/jxb/erj175
Scope of the Report GLP-1 Diabetes Treatment Drugs Market by Segments Drug Type: Liraglutide Dulaglutide Exenatide Others Application: Online Pharmacy Hospital Clinic Region: North America United States Canada Mexico Europe Germany United Kingdom France Italy Spain Nordic BENELUX Rest of Europe East Asia China Japan South Korea South Asia & Pacific India ASEAN Australia & New Zealand Rest of South Asia & Pacific Latin America Brazil Chile Rest of Latin America Middle East & Africa Kingdom of Saudi Arabia Other GCC Countries Turkiye South Africa Other African Union Rest of Middle East & Africa Frequently Asked Questions How big is the GLP-1 diabetes treatment drugs market in 2025
Tesamorelin's longer half-life and ipamorelin's roughly two-hour window are reflected in how those compounds were scheduled in research, whereas sermorelin's very short half-life shaped its own study designs
Enhanced muscle growth and repair Improved sleep quality and daily energy Accelerated fat metabolism Faster tissue healing and regeneration BPC-157 (Body Protection Compound) A powerful healing peptide with regenerative and anti-inflammatory properties
US$ 29.47
US$ 23.99
US$ 20.79
US$ 28.83
US$ 27.62
US$ 22.36
US$ 27.81
US$ 20.02
